Adherence to the Mediterranean Diet, Five-Year Weight Change, and Risk of Overweight and Obesity: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies.


Journal

Advances in nutrition (Bethesda, Md.)
ISSN: 2156-5376
Titre abrégé: Adv Nutr
Pays: United States
ID NLM: 101540874

Informations de publication

Date de publication:
01 02 2022
Historique:
received: 06 03 2021
revised: 07 06 2021
accepted: 06 07 2021
pubmed: 6 8 2021
medline: 2 4 2022
entrez: 5 8 2021
Statut: ppublish

Résumé

Findings from earlier studies on the association between adherence to a Mediterranean diet and risk of overweight/obesity were inconsistent. We summarized cohort studies investigating the association between the Mediterranean diet and risk of overweight and/or obesity and weight change in adults. A systematic search of PubMed, Scopus, ISI Web of Science, and Google Scholar was conducted up to May 2021. Prospective cohorts that examined the Mediterranean diet adherence in adults as the exposure, and overweight and/or obesity or weight change as the outcomes, and reported RRs or β coefficients and 95% CIs as the effect sizes were included. Seven prospective cohort studies were included of which 6 studies (with 244,678 adult participants) reported the risk of overweight and/or obesity, and 4 cohorts (with 436,617 participants) reported the weight change (3 cohorts reported both overweight and/or obesity risk and weight change). Combining 15 effect sizes from 6 cohorts revealed that greater adherence to the Mediterranean diet was significantly associated with a 9% decreased risk of overweight and/or obesity (RR: 0.91; 95% CI: 0.88, 0.94; I2 = 44.7%; PQ-test = 0.031). This association was significant in the case of studies investigating combined overweight and obesity (RR: 0.92; 95% CI: 0.88, 0.96; I2 = 29.4%; PQ-test = 0.166), but not for studies that reported on obesity (RR: 0.68; 95% CI: 0.43, 1.10, I2 = 50.6%, PQ-test = 0.132). Linear dose-response analysis of 6 studies showed a 2% decreased risk of overweight and/or obesity for 1 additional Mediterranean diet score (RR: 0.98; 95% CI: 0.96, 0.99). Each unit increase in the Mediterranean diet score was associated with 0.04 kg less weight gain over 5 y (-0.04 kg; 95% CI: -0.07, -0.02 kg; 13 effect sizes from 4 cohorts). In conclusion, Mediterranean diet adherence is inversely associated with risk of overweight and/or obesity as well as 5-y weight gain and thus has practical importance for public health.

Identifiants

pubmed: 34352891
pii: S2161-8313(22)00534-8
doi: 10.1093/advances/nmab092
pmc: PMC8803490
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

152-166

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition.

Références

Am J Clin Nutr. 2010 Aug;92(2):398-407
pubmed: 20592131
Public Health Nutr. 2017 May;20(7):1322-1330
pubmed: 28003037
Br J Nutr. 2017 Apr;117(8):1189-1197
pubmed: 28509665
J Nutr. 2009 Sep;139(9):1728-37
pubmed: 19571036
Am J Clin Nutr. 2002 Sep;76(3):659-67
pubmed: 12198015
Am J Epidemiol. 1996 Sep 15;144(6):610-21
pubmed: 8797521
J Nutr. 2006 Nov;136(11):2934-8
pubmed: 17056825
Am J Epidemiol. 1992 Jun 1;135(11):1301-9
pubmed: 1626547
Metab Syndr Relat Disord. 2011 Feb;9(1):1-12
pubmed: 20973675
Obes Rev. 2017 Oct;18(10):1200-1209
pubmed: 28730613
Am J Clin Nutr. 2010 Dec;92(6):1484-93
pubmed: 20962161
Eat Weight Disord. 2018 Oct;23(5):605-614
pubmed: 29124678
Adv Nutr. 2019 Mar 1;10(2):205-218
pubmed: 30801613
Int J Obes (Lond). 2016 Nov;40(11):1748-1753
pubmed: 27569683
N Engl J Med. 2003 Jun 26;348(26):2599-608
pubmed: 12826634
JAMA. 2002 May 8;287(18):2414-23
pubmed: 11988062
Am J Clin Nutr. 2010 Oct;92(4):912-21
pubmed: 20810975
N Engl J Med. 2011 Jun 23;364(25):2392-404
pubmed: 21696306
Clin Nutr. 2015 Dec;34(6):1266-72
pubmed: 26499033
Int J Obes (Lond). 2012 Nov;36(11):1455-62
pubmed: 22249228
JAMA. 1998 May 13;279(18):1477-82
pubmed: 9600484
Eur J Clin Nutr. 2008 Apr;62(4):480-7
pubmed: 17327865
Obes Rev. 2014 Sep;15(9):740-8
pubmed: 24815945
Nutrients. 2020 Oct 30;12(11):
pubmed: 33143083
PLoS One. 2012;7(11):e50712
pubmed: 23226361
Public Health Nutr. 2009 Jan;12(1):36-43
pubmed: 18325138
N Engl J Med. 2017 Jul 6;377(1):13-27
pubmed: 28604169
Br J Nutr. 2018 Nov;120(10):1081-1097
pubmed: 30401007
Nutr Diabetes. 2018 Apr 25;8(1):22
pubmed: 29695712
Am J Clin Nutr. 2014 Oct;100(4):1188-97
pubmed: 25099543
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
Br J Nutr. 2015 Dec 28;114(12):2093-102
pubmed: 26458747
Lancet. 2016 Aug 20;388(10046):776-86
pubmed: 27423262
J Nutr. 2015 Aug;145(8):1850-6
pubmed: 26084363
Br J Nutr. 2021 Nov 14;126(9):1389-1397
pubmed: 33441193
Crit Rev Food Sci Nutr. 2017 Oct 13;57(15):3218-3232
pubmed: 26528631
Physiol Behav. 2015 Nov 1;151:88-96
pubmed: 26188140
BMJ. 2020 Apr 1;369:m696
pubmed: 32238384
Nutr Cancer. 2012;64(5):666-73
pubmed: 22564018
Obes Rev. 2008 Nov;9(6):582-93
pubmed: 18547378
Int J Obes (Lond). 2006 Feb;30(2):350-8
pubmed: 16231028
J Clin Biochem Nutr. 2017 Sep;61(2):123-129
pubmed: 28955129

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH